Small increased risk for idiopathic thrombocytopenic purpura seen after first dose with estimated incidence of 1.13 cases per 100,000 doses
Modifiable Cardiovascular Risk Factors Linked to Severity of COVID-19
Strategies that improve cardiovascular health may also improve outcomes for people following COVID-19
Drop in Kawasaki Disease Seen During the COVID-19 Pandemic
Incidence decreased sharply after implementation of nonpharmaceutical interventions, such as mask wearing; seasonal pattern absent
Multifocal Microvascular Injury ID’d in Brain in COVID-19
No SARS-CoV-2 detected in postmortem samples, but brain may be susceptible to microvascular damage